메뉴 건너뛰기




Volumn 18, Issue , 2017, Pages 15-17

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment

Author keywords

Clostridium difficile; Critical illness; Fungemia; Probiotics; Saccharomyces

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B; CASPOFUNGIN; CIPROFLOXACIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; LEVETIRACETAM; METRONIDAZOLE; MICAFUNGIN; PIPERACILLIN PLUS TAZOBACTAM; PROBIOTIC AGENT; SULFAMETHOXAZOLE; SULTAMICILLIN; TEMOZOLOMIDE; TRIMETHOPRIM; VALPROIC ACID; VORICONAZOLE;

EID: 85026196748     PISSN: 22117539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mmcr.2017.07.007     Document Type: Article
Times cited : (50)

References (19)
  • 2
    • 77957367472 scopus 로고    scopus 로고
    • [Microbiota and enteral nutrition]
    • Schneider, S.M., [Microbiota and enteral nutrition]. Gastroenterol. Clin. Biol. 34:Suppl 1 (2010), S57–S61.
    • (2010) Gastroenterol. Clin. Biol. , vol.34 , pp. S57-S61
    • Schneider, S.M.1
  • 3
    • 84926346594 scopus 로고    scopus 로고
    • Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review
    • Xie, C., Li, J., Wang, K., Li, Q., Chen, D., Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review. Travel Med. Infect. Dis. 13:2 (2015), 128–134.
    • (2015) Travel Med. Infect. Dis. , vol.13 , Issue.2 , pp. 128-134
    • Xie, C.1    Li, J.2    Wang, K.3    Li, Q.4    Chen, D.5
  • 4
    • 84999116006 scopus 로고    scopus 로고
    • Reassessing the death risk related to probiotics in critically ill patients
    • Maraolo, A.E., Reassessing the death risk related to probiotics in critically ill patients. Crit. Care, 20(1), 2016, 388.
    • (2016) Crit. Care , vol.20 , Issue.1 , pp. 388
    • Maraolo, A.E.1
  • 5
    • 84982215474 scopus 로고    scopus 로고
    • Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis
    • Manzanares, W., Lemieux, M., Langlois, P.L., Wischmeyer, P.E., Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit. Care, 19, 2016, 262.
    • (2016) Crit. Care , vol.19 , pp. 262
    • Manzanares, W.1    Lemieux, M.2    Langlois, P.L.3    Wischmeyer, P.E.4
  • 7
    • 0345725006 scopus 로고    scopus 로고
    • The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene
    • van der Aa Kühle, A., Jespersen, L., The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. Syst. Appl. Microbiol. 26:4 (2003), 564–571.
    • (2003) Syst. Appl. Microbiol. , vol.26 , Issue.4 , pp. 564-571
    • van der Aa Kühle, A.1    Jespersen, L.2
  • 8
    • 84865240144 scopus 로고    scopus 로고
    • Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics
    • Tiago, F.C., Martins, F.S., Souza, E.L., Pimenta, P.F., Araujo, H.R., Castro, I.M., et al. Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. J. Med. Microbiol. 61:Pt 9 (2012), 1194–1207.
    • (2012) J. Med. Microbiol. , vol.61 , pp. 1194-1207
    • Tiago, F.C.1    Martins, F.S.2    Souza, E.L.3    Pimenta, P.F.4    Araujo, H.R.5    Castro, I.M.6
  • 9
    • 0032919855 scopus 로고    scopus 로고
    • Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa
    • Castagliuolo, I., Riegler, M.F., Valenick, L., LaMont, J.T., Pothoulakis, C., Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun. 67:1 (1999), 302–307.
    • (1999) Infect. Immun. , vol.67 , Issue.1 , pp. 302-307
    • Castagliuolo, I.1    Riegler, M.F.2    Valenick, L.3    LaMont, J.T.4    Pothoulakis, C.5
  • 10
    • 33645455337 scopus 로고    scopus 로고
    • Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease
    • McFarland, L.V., Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am. J. Gastroenterol. 101:4 (2006), 812–822.
    • (2006) Am. J. Gastroenterol. , vol.101 , Issue.4 , pp. 812-822
    • McFarland, L.V.1
  • 11
    • 85000580131 scopus 로고    scopus 로고
    • Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial
    • (ofw011)
    • Ehrhardt, S., Guo, N., Hinz, R., Schoppen, S., May, J., Reiser, M., et al. Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial. Open Forum Infect. Dis., 3(1), 2016 (ofw011).
    • (2016) Open Forum Infect. Dis. , vol.3 , Issue.1
    • Ehrhardt, S.1    Guo, N.2    Hinz, R.3    Schoppen, S.4    May, J.5    Reiser, M.6
  • 12
    • 84861908072 scopus 로고    scopus 로고
    • Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial
    • Pozzoni, P., Riva, A., Bellatorre, A.G., Amigoni, M., Redaelli, E., Ronchetti, A., et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am. J. Gastroenterol. 107:6 (2012), 922–931.
    • (2012) Am. J. Gastroenterol. , vol.107 , Issue.6 , pp. 922-931
    • Pozzoni, P.1    Riva, A.2    Bellatorre, A.G.3    Amigoni, M.4    Redaelli, E.5    Ronchetti, A.6
  • 13
    • 85018468803 scopus 로고    scopus 로고
    • Effectiveness of probiotics in reducing the incidence of Clostridium difficile-associated diarrhea in elderly patients: a systematic review
    • Vernaya, M., McAdam, J., Hampton, M.D., Effectiveness of probiotics in reducing the incidence of Clostridium difficile-associated diarrhea in elderly patients: a systematic review. JBI Database Syst. Rev. Implement. Rep. 15:1 (2017), 140–164.
    • (2017) JBI Database Syst. Rev. Implement. Rep. , vol.15 , Issue.1 , pp. 140-164
    • Vernaya, M.1    McAdam, J.2    Hampton, M.D.3
  • 14
    • 84858637080 scopus 로고    scopus 로고
    • Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea
    • Dinleyici, E.C., Eren, M., Ozen, M., Yargic, Z.A., Vandenplas, Y., Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin. Biol. Ther. 12:4 (2012), 395–410.
    • (2012) Expert Opin. Biol. Ther. , vol.12 , Issue.4 , pp. 395-410
    • Dinleyici, E.C.1    Eren, M.2    Ozen, M.3    Yargic, Z.A.4    Vandenplas, Y.5
  • 15
    • 70350441932 scopus 로고    scopus 로고
    • Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children
    • Savaş-Erdeve, S., Gökay, S., Dallar, Y., Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children. Turk. J. Pediatr. 51:3 (2009), 220–224.
    • (2009) Turk. J. Pediatr. , vol.51 , Issue.3 , pp. 220-224
    • Savaş-Erdeve, S.1    Gökay, S.2    Dallar, Y.3
  • 16
    • 54049107346 scopus 로고    scopus 로고
    • Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin
    • Lolis, N., Veldekis, D., Moraitou, H., Kanavaki, S., Velegraki, A., Triandafyllidis, C., et al. Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Crit. Care, 12(2), 2008, 414.
    • (2008) Crit. Care , vol.12 , Issue.2 , pp. 414
    • Lolis, N.1    Veldekis, D.2    Moraitou, H.3    Kanavaki, S.4    Velegraki, A.5    Triandafyllidis, C.6
  • 17
    • 0036278211 scopus 로고    scopus 로고
    • Seven cases of fungemia with Saccharomyces boulardii in critically ill patients
    • Lherm, T., Monet, C., Nougière, B., Soulier, M., Larbi, D., Le Gall, C., et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 28:6 (2002), 797–801.
    • (2002) Intensive Care Med. , vol.28 , Issue.6 , pp. 797-801
    • Lherm, T.1    Monet, C.2    Nougière, B.3    Soulier, M.4    Larbi, D.5    Le Gall, C.6
  • 18
    • 77951026738 scopus 로고    scopus 로고
    • Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)
    • Cohen, S.H., Gerding, D.N., Johnson, S., Kelly, C.P., Loo, V.G., McDonald, L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:5 (2010), 431–455.
    • (2010) Infect. Control Hosp. Epidemiol. , vol.31 , Issue.5 , pp. 431-455
    • Cohen, S.H.1    Gerding, D.N.2    Johnson, S.3    Kelly, C.P.4    Loo, V.G.5    McDonald, L.C.6
  • 19
    • 84900563292 scopus 로고    scopus 로고
    • Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum
    • Santino, I., Alari, A., Bono, S., Teti, E., Marangi, M., Bernardini, A., et al. Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum. Int. J. Immunopathol. Pharmacol. 27:1 (2014), 143–146.
    • (2014) Int. J. Immunopathol. Pharmacol. , vol.27 , Issue.1 , pp. 143-146
    • Santino, I.1    Alari, A.2    Bono, S.3    Teti, E.4    Marangi, M.5    Bernardini, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.